Retatrutide (LY3437943)
Peptide Research Reference Retatrutide (LY3437943) Retatrutide is a synthetic peptide characterized in laboratory settings as a multi-receptor agonist targeting specific G protein-coupled receptor pathways. It serves as a molecular tool for investigating complex signaling cascades involved in cellular regulatory mechanisms.
Overview & Classification
Retatrutide is classified as a synthetic peptide, specifically categorized within the group of multi-agonist molecules designed to interact with multiple receptor classes simultaneously. Structurally, it is a modified polypeptide chain engineered to exhibit high affinity for specific cell-surface receptors. Use primary literature or an authoritative database for standardized sequence and identifier information, and any available lot-specific document for the supplied material. A database record does not establish the identity or purity of a lot.
Molecular Target & Mechanism
In vitro research models indicate that Retatrutide functions as a triple agonist, exhibiting binding affinity for the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R). The mechanism involves the activation of these receptors, which are members of the class B G protein-coupled receptor family. • GCGR Interaction: The molecule is studied for its ability to engage the glucagon receptor, which modulates intracellular cyclic adenosine monophosphate (cAMP) levels. • GIPR Interaction: Laboratory investigations focus on the binding kinetics of the peptide at the GIP receptor site, a pathway involved in transmembrane signaling. • GLP-1R Interaction: The peptide is examined for its capacity to act as a ligand for the GLP-1 receptor, influencing downstream signaling proteins within the cell. The simultaneous modulation of these three receptors allows researchers to observe the cross-talk between these distinct signaling pathways in controlled laboratory environments.
Why Researchers Use It
Retatrutide is utilized in laboratory research as a probe to investigate the integrated signaling dynamics of the GCGR, GIPR, and GLP-1R systems. By utilizing a single molecule with triple-agonist properties, researchers can analyze how receptor co-activation influences cellular signaling networks compared to the activation of individual receptors. The compound is frequently employed in cell culture assays to characterize the potency and efficacy of receptor signaling. It serves as a tool for mapping the intracellular cascades that follow receptor binding, such as the activation of adenylate cyclase and the subsequent production of secondary messengers.
Research Context
Research involving Retatrutide is situated within the broader field of receptor pharmacology and signal transduction. Laboratory studies investigate how multi-agonist ligands can be engineered to achieve specific binding profiles across related receptor families. Investigations often focus on the spatial and temporal aspects of receptor activation. By utilizing this peptide in various cell lines, researchers aim to understand the structural requirements for receptor engagement and the subsequent modulation of cellular signaling pathways. This work contributes to the fundamental understanding of how peptide-based ligands interact with transmembrane protein structures.
Handling, Stability & Storage for Laboratory Use
For laboratory applications, Retatrutide should be handled according to standard protocols for synthetic peptides. The compound is typically supplied as a lyophilized powder, which requires careful reconstitution for in vitro assays. • Solution preparation: Validate solvent, pH, concentration, vehicle controls, and contamination controls for the specific cell assay. • Storage: Follow the labeled condition and validate solution matrix, concentration, container, temperature, hold time, and freeze-thaw limits. • Handling: Establish freeze-thaw limits and container recovery from method data; low-binding tubes may help some methods but require compatibility verification.
Purity & Analytical Verification
Material characterization is one variable in research reliability. HPLC may estimate relative chromatographic purity and mass spectrometry may support identity; verify the methods and results actually available for the exact lot. When a lot-specific COA or analytical report is available, review its methods, results, units, specifications, and lot linkage. A peak-area purity percentage is not necessarily a percentage of total sample mass, and the document does not ensure experimental reproducibility.
How It Relates to Other Compounds in Its Research Class
Retatrutide is part of a class of engineered peptides that target G protein-coupled receptors. It is often compared in laboratory settings to single-agonist peptides (targeting only GLP-1R) or dual-agonist peptides (targeting both GIPR and GLP-1R). The primary distinction in research models is the receptor-binding profile. While other compounds may target one or two receptors, Retatrutide’s triple-agonist profile allows for the investigation of tripartite receptor signaling. This comparative approach is essential for understanding how the breadth of receptor engagement influences the intensity and duration of intracellular signaling responses in controlled experimental models.
Frequently Asked Research Questions
What is the primary utility of Retatrutide in an in vitro setting? It is used as a pharmacological tool to study the simultaneous activation of GCGR, GIPR, and GLP-1R pathways to observe how these receptors interact within a unified signaling network. How does the triple-agonist profile affect experimental design? It allows researchers to compare the signaling cascades triggered by multi-receptor engagement against those triggered by selective ligands, providing data on receptor cross-talk. What analytical methods confirm the identity of the peptide? HPLC may estimate relative chromatographic purity and mass spectrometry may support identity. Confirm whether those methods and their results are actually documented for the exact lot. Are there specific storage requirements for this peptide? Use product-specific storage information for the dry material and a validated procedure for any solution; lyophilization and low temperature alone do not establish stability. Research use only — no structure/function or human-use claims are made. This information is provided for educational purposes regarding laboratory research and chemical characterization.
References
- Jastreboff et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2 Trial
- ClinicalTrials.gov record NCT04881760
- ClinicalTrials.gov phase 3 TRIUMPH-Outcomes record NCT06383390
Authoritative sources cited for research context. Research use only — not medical advice.